ANI Pharmaceuticals
ANIP
ANIP
141 hedge funds and large institutions have $325M invested in ANI Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $499M → $325M (-$174M)
67% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 39
Holders
141
Holding in Top 10
–
Calls
$3.43M
Puts
$1.25M
Top Buyers
| 1 | +$5.12M | |
| 2 | +$4.05M | |
| 3 | +$2.85M | |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$2.82M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.15M |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$4M | |
| 3 | -$3.7M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.07M |
| 5 |
Man Group
London,
United Kingdom
|
-$1.75M |